Stryker (SYK) Cash from Investing Activities Growth (5y) (2014 - 2026)
Stryker (SYK) Cash from Investing Activities Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.39 Bn | 18.98 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.90% |
| Mar 31, 2026 | -14.02% |
| Dec 31, 2025 | 41.23% |
| Sep 30, 2025 | -36.00% |
| Jun 30, 2025 | 2.33% |
| Mar 31, 2025 | -90.93% |
| Dec 31, 2024 | 15.87% |
| Sep 30, 2024 | -63.48% |
| Jun 30, 2024 | 13.88% |
| Mar 31, 2024 | -6.13% |
| Dec 31, 2023 | 37.76% |
| Sep 30, 2023 | 1.45% |
| Jun 30, 2023 | -18.93% |
| Mar 31, 2023 | 31.08% |
| Dec 31, 2022 | 18.84% |
| Sep 30, 2022 | 15.87% |
| Jun 30, 2022 | 4.56% |
| Mar 31, 2022 | -78.99% |
| Dec 31, 2021 | -12.15% |
| Sep 30, 2021 | -19.35% |